What is the Ginkgo Bioworks Holdings Inc (DNA) price today?

The price of Ginkgo Bioworks Holdings Inc (DNA) today is $7.81. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/DNA

Buy & Sell Ginkgo Bioworks Holdings Inc (DNA) – Ginkgo Bioworks Holdings Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Ginkgo Bioworks (DNA) trades at $8.44, up 2.8% on the day. The company is undergoing a significant strategic pivot, divesting non-core assets like its mobile device business and biosecurity unit to focus on its autonomous lab infrastructure and AI-driven Ginkgo Cloud Lab platform. While the company maintains a high gross margin of 72.39%, it is deeply unprofitable with a net margin of -183.81% and negative cash flow, reflecting heavy investment in its new strategic direction.

The outlook hinges on Ginkgo's ability to monetize its pivot to autonomous labs and AI, but significant execution risk remains. Analyst sentiment is mixed with a slight lean toward 'Buy' (45%), yet persistent insider selling and substantial ongoing losses present clear risks for shareholders. The stock's trajectory will be dictated by the company's success in turning its technology investments into sustainable revenue growth and a path to profitability.

Read full analysis

Key Stats

Market Cap
$522.64M
Sector
Health
3M Drawdown
-46.01%
Enterprise Value
$539.91M
Dividend Yield
-
Typical Hold Time
1 days

$7.81

52W Low: $5.48

30 Mar 2026

52W High: $16.14

03 Oct 2025

Ginkgo Bioworks Holdings Inc (DNA) is currently valued at a market capitalization of $522.64M, with an enterprise value of $539.91M. Over the past 52 weeks, Ginkgo Bioworks Holdings Inc has traded between a low of $5.48 and a high of $16.14, highlighting its annual price range. Over the past three months, Ginkgo Bioworks Holdings Inc has recorded a drawdown of -46.01%, reflecting recent price volatility. On average, investors hold Ginkgo Bioworks Holdings Inc for approximately 1 days, indicating typical investor behavior on the platform.

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Technical Indicators

Overall Summary

Bearish (16)Neutral (10)Bullish (1)

News

Globe Newswire2 year ago

Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023 - Global Forecast to 2030 - Revolutionizing Healthcare with Targeted Drug Delivery and Minimally Invasive Surgeries

Globe Newswire2 year ago

Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA

The Motley Fool2 year ago

Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today

Benzinga2 year ago

Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development

The Motley Fool2 year ago

Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$522.64M
Sector
Health
3M Drawdown
-46.01%
Enterprise Value
$539.91M
Dividend Yield
-
Typical Hold Time
1 days

$7.81

52W Low: $5.48

30 Mar 2026

52W High: $16.14

03 Oct 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Ginkgo Bioworks Holdings Inc (DNA) – Ginkgo Bioworks Holdings Inc Price Today

Aura AI Summary

Key Stats

About Ginkgo Bioworks Holdings Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store